Andrei Floroiu | President and CEO |
James Cummings | Chief Medical Officer |
Sean Tucker | SVP and Chief Scientific Officer |
Phil Lee | CFO |
Brant Biehn | SVP and Business Operations |
Charles Duncan | Cantor Fitzgerald |
Mayank Mamtani | B. Riley Securities |
Greetings, and welcome to the Vaxart Business Update and Second Quarter 2023 Financial Results Conference Call. A question-and-answer session will follow management's opening remarks. Individual investors may submit written questions to ir@vaxart.com.
As a reminder, this conference is being recorded.
I would now like to turn the webcast over to your host, Brant Biehn, Senior Vice President and Business Operations.